Apyx Medical Corporation Received FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring
On April 28, 2023, Apyx Medical Corporation, the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, received 510(k) US Food and Drug Administration clearance for the utilization of the Renuvion APR Handpiece for the coagulation of subcutaneous soft tissues following liposuction for aesthetic body contouring purposes.
With this, the Renuvion APR handpiece became the only device to have a 510(k) clearance for use following liposuc...